Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_assertion type Assertion NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_head.
- NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_assertion description "[To further characterize RCC T-cell responses and identify relevant RCC-associated antigens, we did a detailed analysis of CD8+ T-cell responses in two vaccinated RCC patients who generated the greatest magnitude of DTH response and also displayed a strong clinical response to vaccination (>90% reduction in metastatic tumor volume).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_provenance.
- NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_assertion evidence source_evidence_literature NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_provenance.
- NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_assertion SIO_000772 15705910 NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_provenance.
- NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_assertion wasDerivedFrom befree-20140225 NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_provenance.
- NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_assertion wasGeneratedBy ECO_0000203 NP423216.RAMTsjueXAk-L3S8cglEOYxzEyukdivvobvO0BnYhzChk130_provenance.